LEAH Labs on Wefunder

curing cancer in dogs

Raise to date: $362,752

Reporting Date: 01/19/2020

Key Stats

Minimum Raise

$100,000

Maximum Raise

$1,070,000

Likelihood of Max Unlikely
Start Date

09/05/2019

Stop Date

02/20/2020

Days Remaining

31

Security Type

SAFE

Investment Minimum

$100

Deal Type

Deal to Watch


Investment Summary

Status

Active

# of Investors

582

% of Minimum Raised

363%

% of Maximum Raised

34%

Dollars Per Day to Reach Max

$22,814

DPD* Committed

$2,667

DPD* Category

$0

DPD* All Companies

$1,121

Kingscrowd Momentum

$362,752

Total Dollars Raised

Commitments

Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

LEAH Labs, with a valuation cap of $6 million, is raising crowdfunding on WeFunder. The company is developing CAR T cell therapy to treat cancer in dogs. LEAH Labs has a patented technology that uses CRISPR to harness and reprogram T cells that find and kill cancer cells in dogs. LEAH Labs was founded by an experienced team including Stephen Carl Ekker, Jonathan Mochel and Saad Kenderian, and has raised more than $250,000 since its inception. The current crowdfunding round has a minimum raise of $100,000 and a maximum raise of $1,070,000, and the funds will be used towards research & development, business development, and maintaining and hiring talent. LEAH Labs is backed by Y Combinator and is led by PhD experts in gene editing, cell therapy, and veterinary oncology.

INVEST NOW